H-ras antisense oligodeoxynucleotide isis 2503 Uses, Dosage, Side Effects and more
H-ras antisense oligodeoxynucleotide isis 2503 is under investigation in clinical trial NCT00004193 (H-ras antisense oligodeoxynucleotide isis 2503 in Treating Patients With Metastatic And/or Locally Recurrent Colorectal Cancer).
| Trade Name | H-ras antisense oligodeoxynucleotide isis 2503 |
| Generic | ISIS 2503 |
| ISIS 2503 Other Names | H-ras antisense oligodeoxynucleotide isis 2503 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
